News | May 07, 2026
Neuland seals deal with LIR Life Sciences for transdermal GLP-1
CDMO to advance biotech’s novel cell-penetrating peptides for next-generation obesity therapies
CDMO to advance biotech’s novel cell-penetrating peptides for next-generation obesity therapies
Subscribe To Our Newsletter & Stay Updated